Unknown

Dataset Information

0

Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood-brain barrier permeability.


ABSTRACT: Highly selective mTOR inhibitors have been discovered through the exploration of the heteroaromatic ring engaging the binding affinity region in mTOR kinase. Compound 11 showed predicted BBB permeability in a MDCK-MDR1 permeability in vitro assay, being the first pyrimido-pyrrolo-oxazine with potential application in the treatment of neurological disorders.

SUBMITTER: Borsari C 

PROVIDER: S-EPMC8128076 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4576686 | biostudies-literature
| S-EPMC6770420 | biostudies-literature
| S-EPMC3529132 | biostudies-literature
| S-EPMC2773134 | biostudies-literature
| S-EPMC2980237 | biostudies-literature
| S-EPMC4423729 | biostudies-literature